Search Results - "Qiu, Zhixiang"

Crowd Counting and Localization in Haze and Rain

Yuan, Weijun, Li, Zhan, Li, Xiaohan, Fang, Liangda, Zhang, Qingfeng, Qiu, Zhixiang

2024 IEEE International Conference on Multimedia and Expo (ICME)

Clinical characteristics and prognosis of a Chinese cohort with systemic light chain amyloidosis: a single-center study

Xie, Weiwei, Wang, Qian, Zhou, Fude, Wang, Suxia, Sun, Yuhua, Cen, Xinan, Ren, Hanyun, Qiu, Zhixiang^{Aff1, IDs12185023036178_cor8}, Dong, Yujun^{Aff1, IDs12185023036178_cor9}

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

[Efficacy comparison between Ph⁺ ALL patients treated with chemotherapyplus tyrosine kinase inhibitors followed by allo-HSCT and Ph-ALL patients with allo-HSCT: a case control study from a single center].

Hu J; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Wang L; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Li Y; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Qiu Z; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Xu W; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Sun Y; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Yin Y; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Liu W; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Ou J; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Wang M; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Wang W; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Liang Z; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Cen X; Department of Hematology, Peking University First Hospital, Beijing 100034, China., Ren H; Department of Hematology, Peking University First Hospital, Beijing 100034, China.

Controlled Clinical Trial; Journal Article , 2015

[Combination of busulfan with increased-dose of fludarabine as conditioning regimen for MDS and MDS-AML patients with allo-HSCT].

Yuan J; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Ren H; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Qiu Z; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Li Y; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Wang M; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Liu W; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Xu W; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Sun Y; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Wang L; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Liang Z; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Dong Y; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Ou J; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Wang W; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Yin Y; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Cen X; Department of Hematology, Peking University First Hospital, Beijing　100034, China., Wang Q; Department of Hematology, Peking University First Hospital, Beijing　100034, China.

Journal Article , 2015